Bipolar catheter defibrillation in dogs using trapezoidal waveforms of various tilts.
The choice of defibrillating waveform is critical in determining the size, battery life, and effectiveness of an automatic implantable defibrillator (AID). The trapezoidal (truncated exponential) waveform is well suited for the AID and its use can be optimized by the selection of appropriate values of pulse duration and tilt. The purpose of this study was to determine the dependence of the threshold peak current (the minimum peak current necessary to defibrillate the ventricles) on pulse duration and tilt for a bipolar catheter electrode configuration. Successive fibrillation-defibrillation trials were performed in 30 dogs anesthetized with sodium pentobarbital (30 mg/kg). The defibrillating pulse was applied via a bipolar-electrode catheter positioned such that the electrodes were located in the right ventricle at the apex and in the superior vena cava. The threshold peak current was determined in each dog for trapezoidal waveforms with 80%, 65%, 50%, and less than 5% tilt and with pulse durations of 2, 5, 10, 15, and 20 milliseconds. From a total of 600 threshold peak-current values, a strength-duration curve was derived for each value of tilt. The threshold peak current dose (peak current divided by body weight) increased with increasing tilt and decreasing duration. The threshold average current dose (average current over the duration of the defibrillating pulse divided by body weight) was IAV = 0.26 + 0.47/d, where d is the pulse duration in milliseconds and IAV is the average current in amperes per kilogram. If catheter apparent impedance is known, the minimum capacitance and output voltage necessary for defibrillation can be inferred from the strength-duration curves. From these data one can quantitatively assess the effect of trapezoidal waveform shape on the design criteria for the AID.
D000818:Animals; D001835:Body Weight; D006328:Cardiac Catheterization; D004554:Electric Countershock / Q000295:instrumentation / Q000379:methods*; D004594:Electrophysiology; D005260:Female; D008297:Male; D009206:Myocardium / Q000473:pathology; D014693:Ventricular Fibrillation / Q000628:therapy*